Table 2.

Multiple logistic regression analyses for independent risk factors of NOAF

	Estimated β	OR (95% CI)	P value
Model 1
Age, years	0.12	1.127 (1.063–1.196)	P < 0.001
Hs-CRP, mg/L	0.034	1.034 (1.018–1.05)	P < 0.001
BNP, pg/ml	0.001	1 (0.999–1.001)	0.446
Model 2
Age, years	0.118	1.125 (1.036–1.221)	0.005
Hs-CRP, mg/L	0.026	1.026 (1.01–1.048)	0.013
LAD, mm	0.055	1.057 (0.921–1.213)	0.43
LVEF, %	− 0.018	0.983 (0.932–1.036)	0.516
Model 3
Hs-CRP, mg/L	0.028	1.028 (1.016–1.04)	P < 0.001
CHADS2 score	0.338	1.403 (1.025–1.92)	0.035
Model 4
Hs-CRP, mg/L	0.028	1.028 (1.015–1.041)	P < 0.001
CHA2DS2-VASc score	0.425	1.529 (1.173–1.994)	0.002

Variables included in model 1 are age, hs-CRP and BNP. Variables included in model 2 are age, hs-CRP, LAD and LVEF. Variables included in model 3 are hs-CRP and the CHADS2 score. Variables included in model 4 are hs-CRP and the CHA2DS2-VASc score

NOAF, new-onset atrial fibrillation; Hs-CRP, high sensitive c-reactive protein; BNP, B-type natriuretic peptide; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LAD, left atrium diameter; LVEF, left ventricular ejection fraction;